Ireland - English - HPRA (Health Products Regulatory Authority)

flynn pharma limited - cefuroxime sodium - powder for solution for injection/infusion - 1.5 gram(s) - second-generation cephalosporins; cefuroxime

Ireland - English - HPRA (Health Products Regulatory Authority)

flynn pharma limited - cefuroxime sodium - powder for solution for injection/infusion - 750 milligram(s) - second-generation cephalosporins; cefuroxime

Australia - English - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - 61225 - treponema pallidum immunoglobulin g (igg)/igm antibody ivd, kit, agglutination - beckman coulter pk tp system is intended for the qualitative screening of blood donors for the detection of treponema pallidum igg and igm antibodies in human serum or edta plasma using the beckman coulter pk7300, automated microplate system. the test is based on the principle of agglutination and pattern recognition. the beckman coulter pk tp system utilizes fixed chicken erythrocytes sensitized with components of the pathogenic t. pallidum

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - caspofungin acetate, quantity: 77.7 mg - injection, powder for - excipient ingredients: mannitol; sucrose; sodium hydroxide; hydrochloric acid - caspofungin an is indicated for:,? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics,? treatment of:,-invasive candidiasis, including candidaemia,-oesophageal candidiasis,-invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - caspofungin acetate, quantity: 55.5 mg (equivalent: caspofungin, qty 50 mg) - injection, powder for - excipient ingredients: sodium hydroxide; sucrose; hydrochloric acid; mannitol - caspofungin an is indicated for:,? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics,? treatment of:,-invasive candidiasis, including candidaemia,-oesophageal candidiasis,-invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

Malta - English - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - micafungin sodium - powder for concentrate for solution for infusion - micafungin sodium 50 mg - antimycotics for systemic use

Malta - English - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - micafungin sodium - powder for concentrate for solution for infusion - micafungin sodium 100 mg - antimycotics for systemic use

Malta - English - Medicines Authority

ebewe pharma gmbh nfg. kg - oxaliplatin 5 mg/ml - powder for solution for infusion

Australia - English - Department of Health (Therapeutic Goods Administration)

becton dickinson pty ltd - 32172 - infusion stopcock - designed to supply the blood stream with fluids or medication coming from one or two diferent sources via an iv cannula or extension tube.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - esmolol hydrochloride, quantity: 2500 mg - injection, powder for - excipient ingredients: - supraventricular tachycardia,brevibloc (esmolol hcl) is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. brevibloc is also indicated in non compensatory sinus tachycardia where, in the physician's judgement, the rapid heart rate requires specific intervention. brevibloc is not intended for use in chronic settings where transfer to another agent is anticipated or for treatment periods greater than 24 hours duration.